Structural and temporal dynamics of pediatric influenza prevention and treatment: a comprehensive bibliometric

Junbin Hong1, Yingying Lin1, Xiaomei Huang1

  • 1Department of Pediatric, The Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.

Insights

This bibliometric analysis reveals key trends in pediatric influenza research, highlighting immunization and antiviral therapies. Future work should focus on mixed infections and vaccine development for better global control.

Area of Science:

  • Public Health
  • Virology
  • Pediatrics

Background:

  • Pediatric influenza presents a significant global health challenge, necessitating ongoing advancements in vaccines, antivirals, and infection control.
  • The rapid expansion of scientific literature requires systematic synthesis to understand developments in pediatric influenza research.
  • Bibliometric analysis is essential for mapping the evolution, hotspots, and emerging trends in this field.

Purpose of the Study:

  • To conduct a comprehensive bibliometric analysis of research on pediatric influenza prevention and treatment.
  • To identify historical evolution, research hotspots, and emerging trends in the field of pediatric influenza.
  • To examine structural and temporal trends in the scientific literature from 1994 to 2024.

Main Methods:

  • Data were extracted from the Web of Science Core Collection (WoSCC) covering studies from 1994 to 2024.
  • Bibliometric tools including CiteSpace, HistCite, and Alluvial Generator were employed for multidimensional visual analysis.
  • Analyses included publication trends, citation analysis, collaboration networks, keyword clustering, and identification of emergent keywords.

Main Results:

  • Extensive international scientific collaboration was observed in pediatric influenza research.
  • Keyword clustering identified six emerging research subfields, including influenza A, immunization, and oseltamivir.
  • Persistent themes included live attenuated influenza vaccines and neuraminidase inhibitors, with emerging keywords like syncytial virus and acute respiratory illness.

Conclusions:

  • Pediatric influenza research has evolved through three distinct phases, with current focus on COVID-19 interactions, vaccine hesitancy, efficacy, and antiviral resistance.
  • Future research should prioritize understanding mixed infections, developing broad-spectrum vaccines, and innovating antiviral treatments.
  • Strengthening public health interventions and health communication is crucial for improving global pediatric influenza prevention and control.
Abstract

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...